236 related articles for article (PubMed ID: 32638273)
1. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
[TBL] [Abstract][Full Text] [Related]
2. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections.
Amaral AC; Saavedra PHV; Oliveira Souza AC; de Melo MT; Tedesco AC; Morais PC; Soares Felipe MS; Bocca AL
Colloids Surf B Biointerfaces; 2019 Feb; 174():409-415. PubMed ID: 30481701
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
Liao H; Liu S; Wang H; Su H; Liu Z
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
[TBL] [Abstract][Full Text] [Related]
4. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
da Silva JT; Dantas de Sousa PH; Costa AF; de Menezes LB; Alves SF; Pellegrini F; Amaral AC
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37947253
[TBL] [Abstract][Full Text] [Related]
6. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
9. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
[TBL] [Abstract][Full Text] [Related]
12. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
14. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
[TBL] [Abstract][Full Text] [Related]
15. Pulsatilla decoction inhibits Candida albicans proliferation and adhesion in a mouse model of vulvovaginal candidiasis via the Dectin-1 signaling pathway.
Yang L; Wu H; Qiu W; Guo L; Du X; Yu Q; Gao J; Luo S
J Ethnopharmacol; 2018 Sep; 223():51-62. PubMed ID: 29775695
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.
Elizondo-Zertuche M; Robledo-Leal E; González JG; Ceceñas LA; González GM
Rev Iberoam Micol; 2015; 32(1):30-3. PubMed ID: 24071640
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
18. Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis.
Chen L; Wang Z; Liu L; Qu S; Mao Y; Peng X; Li YX; Tian J
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):9037-9055. PubMed ID: 31659418
[TBL] [Abstract][Full Text] [Related]
19. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
[TBL] [Abstract][Full Text] [Related]
20. Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
Facchinatto WM; Galante J; Mesquita L; Silva DS; Martins Dos Santos D; Moraes TB; Campana-Filho SP; Colnago LA; Sarmento B; das Neves J
Acta Biomater; 2021 Apr; 125():312-321. PubMed ID: 33639312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
